Those exits explain the main number in its quarterly report, released on 28 October 2026. Annual recurring revenue (ARR) fell to $3.49 million at 30 September, from $3.84 million three months earlier. The company says the exits removed about $509,000 of ARR. Former reseller …
The reasoning is that AOC is made from ingredients regarded as safe and is aimed at the complementary medicine market. The board believes the published literature already explains the likely mechanism of action. This is a lower-cost route than a clinical programme, but it …
The offer follows a $1.215 million placement at the same price, completed in two tranches. Together, the raisings are meant to fund Nevada drilling andWorking Capitalafter disappointing results at the company's Byrock copper-gold project in New South Wales.
Those results matter because of the company's cash position. Its September quarter Appendix 5B, released on 26 October 2026, showed $860,000 in cash and an estimated 1.45 quarters of funding, and Avira has said it plans to raise funds when the board considers the …
Because the minimum was not met, AXP says it will deal with the application money as the Corporations Act requires. The announcement does not say whether that means refunds. A separate shortfall offer at the same price, with one free option for every two …
The constraint is cash. The company's Appendix 5B shows $1.09 million at 30 September, after quarterly outgoings of $984,000, for an estimated 1.11 quarters of funding. The board said it would considerOptionsto support operations and believes it has encouraging prospects of raising sufficient funds. …
As a result, Beam now has a smaller revenue base and less cash. According to its Appendix 4C, released on 26 October 2026, it held $2.92 million at 30 September and generated $160,000 of positive operating cash flow in the quarter. The company expects …
According to its Appendix 4C released on 30 October 2026, the company held $31,000 in cash at 30 September after a net operating outflow of $1.455 million. It reported 0.02 quarters of funding available, yet said it did not expect to need aCapitalraising. That …
The company said it intends to consider a further capital raising after itsAnnual General Meetingon 26 November 2026, subject to shareholder approval and market conditions. Among the AGM resolutions is approval of an additional 10%PlacementFacilityunder Listing Rule 7.1A, which would give the board more …
Advent's main asset is its interest in the offshore PEP11 permit off New South Wales. Its legal fight over that permit is continuing. After the Federal Court dismissed Advent's application for judicial review on 17 June 2026, Advent lodged an appeal with the Full …